April 17, 2025 (MLN): In a landmark move to enhance Pakistan’s export competitiveness, particularly in the pharmaceutical sector, the Pakistan Single Window (PSW) in collaboration with the Drug Regulatory Authority of Pakistan (DRAP), has launched the Digital Certificate of Pharmaceutical Product (COPP).
This initiative aims to digitalize cross-border trade processes and meet information requirements mandated by importing countries.
The newly launched Digital COPP is part of a broader offering under the DRAP Clearance Gateway, which now also provides electronic Free Sale Certificate, Good Manufacturing Practice (GMP) Certificate, and the No Objection Certificate (NOC) for Exports.
These digital documents streamline regulatory procedures, reduce delays, and align Pakistan’s pharmaceutical export systems with global best practices, according to the press release issued today.
All certificates issued through the PSW platform are secure, electronically verifiable, and embedded with a unique QR code for instant authentication and verification.
The transition from paper-based processes to digital documentation eliminates inefficiencies, ensures regulatory compliance, and boosts transparency and trust in Pakistan’s pharmaceutical exports, especially in highly regulated markets such as the European Union and the United States.
Exports continue to be a cornerstone of Pakistan’s economic development, and initiatives like Uraan Pakistan are supporting businesses in cross-border trade.
The pharmaceutical industry, recognized as a high-potential export sector, recorded exports worth approximately $341 million in FY 2023–24, marking a 3.90% year-on-year growth.
“We are proud to introduce the Digital Certificate of Pharmaceutical Product, which will bring Pakistan’s pharmaceutical industry in line with global best practices,” said Mr. Aftab Haider, CEO of Pakistan Single Window.
He further mentioned that this initiative significantly enhances the efficiency and transparency of our regulatory systems and will boost exports by ensuring our products meet the highest international standards.
"The initiative is in line with the Prime Minister’s vision of a Digital Pakistan,” he added.
Dr. Obaidullah Malik, CEO of DRAP, stated, “The launch of the Digital Certificate of Pharmaceutical Product (COPP), Free Sale Certificate, GMP Certificate, and export NOC through the DRAP Clearance Gateway reflects our commitment to modernizing regulatory practices and strengthening trust in Pakistan’s pharmaceutical sector."
"This milestone underscores our dedication to ensuring the safe, timely, and transparent availability of quality medicines, while enabling exporters to meet international compliance standards with greater efficiency,” he addeed.
This initiative forms a critical part of Pakistan’s broader strategy to digitalize regulatory systems, improve operational efficiency, and foster export-led growth in the pharmaceutical sector.
The Digital COPP marks a significant leap forward in positioning Pakistan as a reliable and competitive player in the global pharmaceutical market.
Copyright Mettis Link News
Posted on: 2025-04-17T11:27:52+05:00
